Search & Evaluation Late TA Lead, Senior Director (CVR)

Position Description Summary
Three Senior/Executive Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external clinical assets in Immunology, Hematology, and Cardiovascular/Renal therapeutic areas. These leaders will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions.

Main Responsibilities & Accountabilities

• Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.
• Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs.
• Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations
• Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics.
• Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy.
• Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions.
• Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution
• Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities.

Qualifications & Experience Requirements

• 15+ years in biopharma with significant experience in clinical development, external innovation, or business development.
• Advanced degree required (MD, PhD, or equivalent).
• Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas.
• Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks.
• Strong understanding of regulatory pathways, market access, and competitive standards of care.

About CSL Plasma
CSL Plasma operates one of the world's largest and most sophisticated plasma collection networks, with over 350 plasma collection centers in the U.S., Europe and China. Headquartered in Boca Raton, Florida, CSL Plasma is a subsidiary of CSL Behring, a global biotherapeutics business and a member of CSL. Plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing lifesaving plasma-derived therapies for people in more than 100 countries. The parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people.

Learn more about CSL Plasma here and CSL, CSL Behring, CSL Seqirus and CSL Vifor here

Learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor here at and CSL Plasma at

Our Benefits
For more information on CSL Plasma benefits visit

You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more visit

Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit